Learn how GLP-1 weight loss medications like Wegovy work in the body and whether over-the-counter GLP-1 supplements are as effective.
t's safe to say the demand for GLP-1 drugs for weight loss has never been higher. Medications like Wegovy and Zepbound have taken the culture by storm. And now, we’re seeing over-the-counter GLP-1But can these non-prescription options deliver the same results, and are they actually safe? Here, obesity medicine doctors give us the low-down on GLP-1 drugs for weight loss and over-the-counter options., an obesity medicine expert who's triple board-certified in internal medicine.
If you ask an obesity medicine doctor whether they're even worth your time , the answer is… probably not.and vitamin D, I don’t usually recommend many other supplements,” Dr. Garcia-Webb says. “And in the case of weight management, I think it is a waste of time. A much better use of time would be to see how a patient could optimize their healthy eating and exercise patterns.”
“The FDA does not routinely test supplements for safety or efficacy. The onus is on the manufacturers and distributors to make sure the product is safe, and the FDA generally will intervene if there are concerns after a product goes to market,” Dr. Garcia-Webb says. “Specifically for GLP-1 supplements, I worry that patients are being misled about the health benefits that can be accomplished with these over-the-counter supplements.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Costco offers eligible members access to GLP-1 weight-loss drugsMembers of the warehouse club can now sign up for a service that offers access to drugs like Ozempic.
Lire la suite »
This food company 'stands out as a beneficiary of GLP-1 adoption'This food company 'stands out as a beneficiary of GLP-1 adoption' - UBS
Lire la suite »
Ozempic babies: Are GLP-1 drugs causing more pregnancies in women?Rooted in fact-based, transparent reporting, Newsy is an award-winning opinion-free network owned by the E.W. Scripps Company that is relentlessly focused on “the why” of every story and seeks to enable a more intimate and immersive understanding of the issues that matter.
Lire la suite »
GLP-1s Like Ozempic, Wegovy Don’t Substantially Increase Thyroid Cancer Risk, Study SuggestsI'm a Texas native covering the latest trends in tech, science and healthcare through explainer pieces on the breaking news team. Previously, I was a Forbes HBCU Scholar writing under the innovation and health and science teams.
Lire la suite »
GLP-1s Like Ozempic, Wegovy Don’t Substantially Increase Thyroid Cancer Risk, Study SuggestsI'm a Texas native covering the latest trends in tech, science and healthcare through explainer pieces on the breaking news team. Previously, I was a Forbes HBCU Scholar writing under the innovation and health and science teams.
Lire la suite »
Study Finds No Evidence of Thyroid Cancer Risk from GLP-1 AnaloguesA Swedish study of over 435,000 people has found no evidence to support concerns that long-term use of GLP-1 analogues, such as Wegovy and Ozempic, increases the risk of thyroid cancer.
Lire la suite »